Showing results (551-560 of 986) with videos related to
Sort By:
Pageof 99
Journal of Clinical and Translational Hepatology|October 2, 2018
Elimination of Hepatitis C in Liver Transplant RecipientsSammy Saab, Youssef Challita, Phillip H Chen, et al.Journal of Clinical and Translational Hepatology|October 2, 2018
Microwave Ablation in Intermediate Hepatocellular Carcinoma in Cirrhosis: An Italian Multicenter Prospective StudyAntonio Giorgio, Pietro Gatti, Luca Montesarchio, et al.Journal of Clinical and Translational Hepatology|October 2, 2018
Hepatitis C Virus Clearance by Direct-acting Antiviral Results in Rapid Resolution of Hepatocytic Injury as Indicated by Both Alanine Aminotransferase and Aspartate Aminotransferase NormalizationTung Huynh, Johnathan Zhang, Ke-Qin HuJournal of Clinical and Translational Hepatology|October 2, 2018
Future Pharmacotherapy for Non-alcoholic Steatohepatitis (NASH): Review of Phase 2 and 3 TrialsJames J Connolly, Kohtaro Ooka, Joseph K LimJournal of Clinical and Translational Hepatology|October 2, 2018
Liver Transplantation for Hepatitis B Virus-related Hepatocellular Carcinoma in Hong KongKa Wing Ma, Kenneth Siu Ho Chok, James Yan Yue Fung, et al.Journal of Clinical and Translational Hepatology|October 2, 2018
Candidate Biomarkers of Liver Fibrosis: A Concise, Pathophysiology-oriented ReviewMattia Bellan, Luigi Mario Castello, Mario PirisiJournal of Clinical and Translational Hepatology|October 2, 2018
Role of SREBPs in Liver Diseases: A Mini-reviewAzam Moslehi, Zeinab Hamidi-ZadJournal of Clinical and Translational Hepatology|June 29, 2018
Risk of Cardiovascular Events in Patients with Primary Biliary Cholangitis - Systematic ReviewDuminda Suraweera, Christina Fanous, Melissa Jimenez, et al.Journal of Clinical and Translational Hepatology|June 29, 2018
Glycosphingolipids Prevent APAP and HMG-CoA Reductase Inhibitors-mediated Liver Damage: A Novel Method for "Safer Drug" Formulation that Prevents Drug-induced Liver InjuryMeir Mizrahi, Tomer Adar, Gadi Lalazar, et al.Journal of Clinical and Translational Hepatology|June 29, 2018
Non-alcoholic Fatty Liver Disease: A Review of Anti-diabetic Pharmacologic TherapiesHeather S Snyder, Sami A Sakaan, Katherine L March, et al.Pageof 99